Category: Compliance Oversight

Audit readiness is a foundational requirement in clinical trial oversight. Regulatory agencies such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and other international health authorities mandate that Sponsors and CROs maintain clear, verifiable documentation of all study-related activities.

The DecenTrialz platform supports Sponsors and CROs in preparing for internal audits, regulatory inspections, and third-party reviews by maintaining structured digital audit trails and reconciliation features, specifically covering the pre-screening phase of participant recruitment.

What Is an Audit Report?

An audit report is a formal record of activities, decisions, communications, and data entries related to a clinical study. It includes:

• Participant matching logs and eligibility records
• Consent documentation timestamps (where applicable)
• Site actions (e.g., applicant acceptance, rejection, communications)
• IRB documentation status
• Any data access or changes made on the platform

These logs serve as defensible evidence of good clinical practice (GCP) and regulatory adherence.

Platform-Generated Audit Support

DecenTrialz offers a structured set of tools to aid in audit preparedness:

Automated Audit Trails

• Immutable logs that capture:
  • User activity (logins, data edits, role assignments)
  • Consent tracking milestones (pre-screening only)
  • Document uploads and version histories
  • Participant communications and timestamps

Exportable Reports

• Generate audit-ready reports by:
  • Study
  • Site
  • Time period (customizable)
  • User role

Reports are available in PDF and CSV formats and include digital timestamps to ensure authenticity.

Reconciliation Logs

• Allow Sponsors and CROs to:
  • Compare pre-screening records against site-reported enrollment
  • Identify missing data entries or mismatched participant statuses
  • Track site-level actions against expected milestones

Reconciliation modules can be integrated with external systems (e.g., CTMS) via secure API.

Best Practices for Audit Preparation

To maintain readiness:

• Regularly download and archive audit logs in secure sponsor environments
• Reconcile platform records with internal tracking sheets at predefined intervals
• Confirm that all IRB and site documentation is up-to-date and timestamped
• Use dashboard filters to identify unresolved flags or anomalies

DecenTrialz offers automated email reminders for missing or outdated compliance elements, enhancing proactive audit hygiene.

Key Note: Audit preparedness is not just about compliance, it’s about demonstrating trustworthiness, transparency, and clinical rigor. With DecenTrialz, all pre-screening activity is automatically captured in a regulatory-compliant format, giving Sponsors and CROs confidence during inspections or cross-functional reviews. Every action on the platform leaves a trace, because every step in clinical research must be traceable.

Risk-Based Monitoring (RBM) is a strategic approach to clinical trial oversight that focuses monitoring resources and efforts on the most critical data elements, processes, and sites. It is endorsed by both the ICH-GCP E6(R2) guidelines and regulatory authorities such as the FDA and EMA as a best practice to enhance trial quality and efficiency without compromising participant safety or data integrity.

The DecenTrialz platform supports RBM frameworks for Sponsors and CROs conducting decentralized or multi-site trials by providing digital tools to identify, monitor, and mitigate risk proactively.

Objectives of Risk-Based Monitoring

RBM is designed to:

• Protect participant safety and rights
• Ensure the reliability of key trial data
• Detect deviations, fraud, or protocol non-compliance early
• Allocate resources more efficiently by prioritizing higher-risk areas
• Reduce unnecessary on-site visits by enabling remote oversight

How DecenTrialz Enables Risk-Based Monitoring

1. Centralized Monitoring Dashboards

• Access real-time insights into site activity, participant status, and data anomalies
• Compare trends across sites using customizable filters (e.g., enrollment pace, dropout rates)
• Receive automated alerts for critical deviations or protocol non-adherence

2. Key Risk Indicators (KRIs) & Thresholds

• Monitor pre-defined KRIs such as:
  • High screen failure rates
  • Unusual participant clustering by site
  • Missing data or long entry delays
• Sponsors and CROs can define custom thresholds for alert triggers and review frequency

3. Remote Source Data Verification (rSDV)

• While DecenTrialz only handles pre-screening, the platform enables secure documentation exchange and logging of pre-consent communications for rSDV purposes
• Site staff can upload credentialed documentation securely for audit preparation

4. Site Performance Benchmarking

• Track site-specific metrics in context of broader benchmarks (regional or study-wide)
• Identify underperforming or overperforming sites for corrective action or best practice sharing

Sponsor & CRO Responsibilities in RBM

Under a risk-based model, Sponsors and CROs must:

• Develop a Monitoring Plan that includes risk assessment, frequency of review, and response workflows
• Use platform-generated data to inform adaptive monitoring schedules
• Maintain complete documentation of all monitoring decisions and responses for inspection readiness

DecenTrialz provides exportable monitoring reports, annotations, and secure document storage to assist with these duties.

Collaboration with Sites

RBM does not eliminate the need for site engagement. It requires:

• Transparent communication with sites about observed patterns
• Supportive dialogue when addressing protocol risks or participant follow-up concerns
• A documented system for site feedback and issue resolution

The platform facilitates this through structured messaging, audit notes, and secure document exchange.

Key Note: Risk-Based Monitoring is not a reduction in oversight ,  it is a smarter, more targeted form of it. DecenTrialz empowers Sponsors and CROs to implement RBM efficiently by offering intelligent monitoring tools, risk alert systems, and flexible reporting dashboards. This leads to better use of resources, faster issue resolution, and improved overall trial quality.